Arvee Laboratories (India) Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 692,000 (47%) | — | ₹422 Cr |
| Retail | — | 692,000 (47%) | — | ₹422 Cr |
| Market Maker | — | 76,000 (5%) | — | ₹5 Cr |
| Σ Total | — | 1,460,000 (100%) | — | ₹8,906 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹122,000 |
| Retail (Max) | 13 | 26,000 | ₹1,586,000 |
| S-HNI (Min) | 14 | 28,000 | ₹1,708,000 |
| B-HNI (Min) | 67 | 134,000 | ₹8,174,000 |
Financial Statements Amount in Crore
| Metric | 31-Mar-17 | 31-Mar-16 | 31-Mar-15 |
|---|---|---|---|
| Revenue | 35 | 27 | 13 |
| Profit After Tax | 2 | 0 | -2 |
| Total Assets | 36 | 35 | 26 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Re-payment of Unsecured Loans of Promoters – 8.41
- 2 Issue Expenses – 0.50
Company Overview
Incorporated in 2012, Arvee Laboratories (India) Limited is Ahmadabad, Gujarat based company engaged in trading in specialty chemicals by getting manufacturing done on job work basis. Company has plans to begin manufacturing of specialty chemicals in near future.
Arvee Labs is mainly engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. Company caters to the demand of both domestic as well as international markets.
Arvee Labs bought land, building and machineries from Skylink Chemicals Private Limited who was engaged in manufacturing of specialty chemicals. Currently, Company is negotiating with IDBI Bank Limited to take over the business of Skylead Chemicals Limited which has been declared as sick by BIFR.